New webinar: “Advances in Understanding and Measuring Glymphatic Clearance in Aging” with Dr. Ruth Benca and Dr. Swati Levendovszky. Watch the video
Neurosom announces Patent for Breakthrough in Personalized Neurophysiological Modeling. Read the Press Release
Dr. Don Tucker, Chief Science Officer and Founder of Neurosom, presented a poster at the Oxford Glymphatic & Brain Clearance Symposium. See Poster
Sleep Duration and Sleep Quality are vital to daily brain health.
Deep and REM sleep, together with uninterrupted sleep cycles, support memory, brain recovery, and waste-clearance physiology.
Yet sleep becomes lighter and more fragmented with age. Every 1% annual decline in deep sleep has been associated with a 27% greater risk of dementia, while older adults with highly fragmented sleep had a 50% greater risk of developing Alzheimer’s disease.
When sleep architecture breaks down, so does the brain’s ability to recover and protect itself.
Our Precision Brain Health Platform measures, predicts, and treats brain health through personalized sleep assessment and closed-loop therapy.
Advanced diagnostic capabilities enable in-clinic assessment with HD EEG for high-fidelity characterization of brain age and cognitive score. Sleep WISP at-home therapy and overnight monitoring includes Glymphatic insight and intervention with personalized optimization for brain recovery during sleep. This closed-loop therapy increases Extracellular Space, which decreases brain impedance measurements and increases Glymphatic flow through brain tissue. Shofner et.al., J SLEEP.
Neurosom goes beyond measuring sleep duration and quality to provide a personalized prediction and treatment of an individual’s brain health.
The AI- powered personal data engine utilizes individual brain models to provide prediction and optimization of the individual’s sleep physiology that supports restorative sleep, glymphatic insight and intervention, and memory capacity.
Neurosom partners with the Sleep and Brain Clinic in California on a new clinical trial of the Sleep WISP.
“Sleep and brain function are critical concerns for many of our patients. As a user of Neurosom’s advanced EEG technology, I’ve been impressed by the scientific rigor and simplicity of their Sleep WISP therapy. Its potential to improve deep & REM sleep offers real promise for cognitive and emotional health. I believe Neurosom is on the leading edge of transforming how we prevent dementia and support healthy aging.”
– Dr. Anil Rama, Founder, Sleep and Brain Clinic
Webinar Series
Progress Report: Investigating the Role of Sleep in Parkinson's Disease with the Sleep WISP
Hear how the medical team at Mt. Sinai is piloting the use of the Sleep WISP and sleep therapy for Parkinson's patients in the hope of impacting the disease and improving patients' lives. This in-depth webinar reviews the progress made in the last year of work with patients and the Sleep WISP, as well as a lively Q&A that dives into the possibilities of future clinical trials. Featuring Dr. Jimenez-Shahed, MD, Professor of Neurology and Medical Director, Movement Disorders, Neuromodulation and Brain Circuit Therapeutics at Mt. Sinai, and Dr. Allison C. Waters, PhD, Assistant Professor of Psychiatry and Neuroscience at the Nash Family Center for Advanced Circuit Therapeutics, Ichan School of Medicine at Mt. Sinai.
Neurosom has received major national press attention in The Washington Post and Oregon Public Broadcasting.
Publications and Patents
US Patent No. 10, 610,121 Method for Desynchronizing Pathological Neural Oscillations.
US Patent No. 11, 045, 131 Truncated Neural Icosahedral Neural Sensor Net and Modular Elements.
Explore the neuroimaging science behind Neurosom through our partner company BEL, whose mission is to advance the study and understanding of the human brain.